Immunotherapy for Prostate Cancer: Where We Are Headed

Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is the fifth cause of cancer-related death. In recent years, a new generation of therapies have been approved for the management of metastatic disease. Moreover, the development of new immunotherapeutic drugs has bec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Mol Sci
Hauptverfasser: Schepisi, Giuseppe, Farolfi, Alberto, Conteduca, Vincenza, Martignano, Filippo, De Lisi, Delia, Ravaglia, Giorgia, Rossi, Lorena, Menna, Cecilia, Bellia, Salvatore Roberto, Barone, Domenico, Gunelli, Roberta, De Giorgi, Ugo
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2017
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5751230/
https://ncbi.nlm.nih.gov/pubmed/29206214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18122627
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge